General Information
Revision date
2019-03-15
Product name
Ranolazine extended-release tablets
Product Synonyms
Ranolazine extended-release tablets, 500 mg and 1000 mg
Chemical name
1-piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3- (2-methoxyphenoxy)propyl]-, (±)-
CAS No.
95635-55-5
1.2.1 Relevant identified uses
indicated for the treatment of chronic angina
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and explosion Expected to be non-combustible Ranolazine is contraindicated in patients Taking strong inhibitors of CYP3A Health Taking inducers of CYP3A With liver cirrhosis No information is available about the potential of this product to
Environmental hazards
produce adverse environmental effects.
